Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. World Health Organization (WHO). Estimated age-standardized incidence and mortality rates World) in 2020, cervix uteri, females, all ages. Globocan 2020. Available at: https://gco.iarc.fr. Accessed 16 April 2021
2. Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2:16086.
3. Au WW, Abdou-Salama S, Sierra-Torres CH, Al-Hendy A. Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Environ Health. 2007;210(6):671–8.
4. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellularestrogen receptor mediates rapid cell signaling. Science. 2005;307:1625–30.
5. Chen D, Carter TH, Auborn KJ. Apoptosis ofcervical cancer cells: implications for adjunct antiestrogentherapy for cervical cancer. Anticancer Res. 2004;24:2649–56.